These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24268382)

  • 1. Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice.
    Jett JR; Peek LJ; Fredericks L; Jewell W; Pingleton WW; Robertson JF
    Lung Cancer; 2014 Jan; 83(1):51-5. PubMed ID: 24268382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.
    Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial.
    Sullivan FM; Farmer E; Mair FS; Treweek S; Kendrick D; Jackson C; Robertson C; Briggs A; McCowan C; Bedford L; Young B; Vedhara K; Gallant S; Littleford R; Robertson J; Sewell H; Dorward A; Sarvesvaran J; Schembri S
    BMC Cancer; 2017 Mar; 17(1):187. PubMed ID: 28284200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.
    Chapman CJ; Healey GF; Murray A; Boyle P; Robertson C; Peek LJ; Allen J; Thorpe AJ; Hamilton-Fairley G; Parsy-Kowalska CB; MacDonald IK; Jewell W; Maddison P; Robertson JF
    Tumour Biol; 2012 Oct; 33(5):1319-26. PubMed ID: 22492236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort.
    Borg M; Wen SWC; Nederby L; Hansen TF; Jakobsen A; Andersen RF; Weinreich UM; Hilberg O
    Lung Cancer; 2021 Aug; 158():85-90. PubMed ID: 34130044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung Test.
    Macdonald IK; Murray A; Healey GF; Parsy-Kowalska CB; Allen J; McElveen J; Robertson C; Sewell HF; Chapman CJ; Robertson JF
    PLoS One; 2012; 7(12):e51002. PubMed ID: 23272083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging.
    Sullivan FM; Mair FS; Anderson W; Armory P; Briggs A; Chew C; Dorward A; Haughney J; Hogarth F; Kendrick D; Littleford R; McConnachie A; McCowan C; McMeekin N; Patel M; Rauchhaus P; Ritchie L; Robertson C; Robertson J; Robles-Zurita J; Sarvesvaran J; Sewell H; Sproule M; Taylor T; Tello A; Treweek S; Vedhara K; Schembri S;
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32732334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer.
    Shan Q; Lou X; Xiao T; Zhang J; Sun H; Gao Y; Cheng S; Wu L; Xu N; Liu S
    Cancer Lett; 2013 Jan; 328(1):160-7. PubMed ID: 22922091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
    Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW
    Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of lung cancer in silicosis patients using a tumor-marker panel.
    Schneider J
    Cancer Biomark; 2010; 6(3-4):137-48. PubMed ID: 20660960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fuzzy-classifier using a marker panel for the detection of lung cancers in asbestosis patients.
    Schneider J; Bitterlich N; Kotschy-Lang N; Raab W; Woitowitz HJ
    Anticancer Res; 2007; 27(4A):1869-77. PubMed ID: 17649786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
    Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
    Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer.
    Wang W; Guan S; Sun S; Jin Y; Lee KH; Chen Y; Wei J
    Tumour Biol; 2014 May; 35(5):4901-5. PubMed ID: 24453033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer.
    Hirasawa Y; Kohno N; Yokoyama A; Kondo K; Hiwada K; Miyake M
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):589-94. PubMed ID: 10673204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of multidisciplinary lung cancer practice.
    Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
    Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.
    Edelsberg J; Weycker D; Atwood M; Hamilton-Fairley G; Jett JR
    PLoS One; 2018; 13(5):e0197826. PubMed ID: 29787590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care.
    Ouwens MM; Hermens RR; Termeer RA; Vonk-Okhuijsen SY; Tjan-Heijnen VC; Verhagen AF; Hulscher MM; Marres HA; Wollersheim HC; Grol RP
    Cancer; 2007 Oct; 110(8):1782-90. PubMed ID: 17724680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts.
    Wu WY; Haider Z; Feng X; Heath AK; Tjønneland A; Agudo A; Masala G; Robbins HA; Huerta JM; Guevara M; Schulze MB; Rodriguez-Barranco M; Vineis P; Tumino R; Kaaks R; Fortner RT; Sieri S; Panico S; Nøst TH; Sandanger TM; Braaten T; Johansson M; Melin B; Johansson M
    Int J Cancer; 2023 May; 152(9):2002-2010. PubMed ID: 36305647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.